The Clorox Company (NYSE:CLX) Shares Sold by OLD National Bancorp IN

OLD National Bancorp IN lessened its stake in shares of The Clorox Company (NYSE:CLX) by 12.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 8,653 shares of the company’s stock after selling 1,221 shares during the period. OLD National Bancorp IN’s holdings in Clorox were worth $1,405,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Catalyst Capital Advisors LLC acquired a new position in shares of Clorox in the 3rd quarter valued at about $54,000. Los Angeles Capital Management LLC lifted its holdings in shares of Clorox by 5.6% during the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after buying an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. grew its position in Clorox by 43.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after purchasing an additional 9,037 shares during the last quarter. Natixis Advisors LLC increased its stake in Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after acquiring an additional 4,839 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in Clorox by 1.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock worth $117,932,000 after purchasing an additional 13,038 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 1.2 %

Shares of NYSE CLX opened at $158.60 on Friday. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock has a market capitalization of $19.63 billion, a PE ratio of 55.26, a P/E/G ratio of 2.91 and a beta of 0.42. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The business’s fifty day moving average price is $162.98 and its 200-day moving average price is $158.03.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue was up 27.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.49 EPS. On average, equities research analysts anticipate that The Clorox Company will post 6.86 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.08%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.

Wall Street Analyst Weigh In

CLX has been the subject of a number of analyst reports. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. DA Davidson lifted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research note on Thursday, January 16th. Finally, Barclays lowered their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a report on Friday, January 17th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $156.07.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.